Dermatology
News from the FDA/CDC
FDA approves ritlecitinib for ages 12 and up for alopecia areata
It is the second JAK inhibitor approved for treating alopecia areata, following approval of baricitinib (Olumiant) in June 2022 for alopecia...
News
FDA passes on olorofim despite critical need for antifungals
There are only four antifungal classes currently available, and there are few new candidates in the pipeline.
News
Warts difficult to eradicate in immunocompromised children
Warts completely resolved with treatment in only 24% of children undergoing active cancer treatment.
News
FDA warns of tattoo ink tied to dangerous infections
“I’ve seen several different infections from tattooing, and they are from organisms that tend to contaminate things in damp, liquid-type...
News
Low-dose oral minoxidil for hair loss soars after NYT article
Dermatologists are increasingly familiar with the medication, but a popular media report seems to have resulted in a quick uptake.
Article
Crusted scalp rash
Article
Persistent scaling rash
News
Tips, contraindications for superficial chemical peels reviewed
Setting expectations is critical as it can take a series of peels over months to see results.
Article
Acute diffuse rash on trunk
News
Cell activity in psoriasis may predict disease severity and provide clues to comorbidities
Skin samples from patients with psoriasis showed more fibroblast clusters in the upper layers of the skin in moderate to severe cases.